|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1992-2-18
|
|
pubmed:abstractText |
Lines of Plasmodium falciparum FCR3 either expressing or not expressing the blood-stage antigen Pf155/RESA were used to analyze the possible involvement of this antigen in the merozoite invasion process in vitro. Antibodies from human sera, affinity purified on synthetic peptides corresponding to C-terminal repeated sequences in Pf155/RESA, were shown to inhibit merozoite invasion of both types of parasites with similar efficiency. Reversal of the invasion inhibition by fusion proteins containing repeated sequences of Pf155/RESA but not of the cross-reactive antigens Ag332 and Pf11.1 indicated that the inhibitory antibodies had similar target antigens in both Pf155/RESA+ and Pf155/RESA- parasites that involved cross-reacting epitopes present in Pf155/RESA. Rabbit antibodies specific for Pf155/RESA repeats inhibited merozoite invasion of Pf155/RESA expressing parasites efficiently but had no or very small effect on the invasion of Pf155/RESA-deficient parasites. In contrast, rabbit antibodies specific for Ag332 repeats as well as human antibodies affinity purified on synthetic Ag332 peptides inhibited merozoite invasion of both types of parasites with high efficiency. A similar inhibition pattern was seen with the human monoclonal antibody 33G2, which has specificity for Ag332 but also cross-reacts with Pf155/RESA and Pf11.1. Taken together, our data suggest that Pf155/RESA and related cross-reactive antigens as well as Ag332 are involved in the merozoite invasion process and may constitute targets for invasion inhibitory antibodies.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-1693414,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-1695598,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-1712912,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-1852169,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-1994367,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-1997422,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2052019,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2055301,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2180822,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2188111,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2209789,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2209790,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2410914,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2419897,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2448335,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2453514,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2455227,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2457214,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2654292,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2677678,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2681427,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2777381,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-2841111,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-3065643,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-3510452,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-3535649,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-3543808,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-4204108,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-4307033,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-6374012,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-6382025,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-6393131,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1730474-781840
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0019-9567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
443-9
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:1730474-Animals,
pubmed-meshheading:1730474-Antibodies, Protozoan,
pubmed-meshheading:1730474-Antigens, Protozoan,
pubmed-meshheading:1730474-Antigens, Surface,
pubmed-meshheading:1730474-Cross Reactions,
pubmed-meshheading:1730474-Humans,
pubmed-meshheading:1730474-Immunoglobulin G,
pubmed-meshheading:1730474-Plasmodium falciparum,
pubmed-meshheading:1730474-Protozoan Proteins,
pubmed-meshheading:1730474-Rabbits
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Involvement of Pf155/RESA and cross-reactive antigens in Plasmodium falciparum merozoite invasion in vitro.
|
|
pubmed:affiliation |
Department of Immunology, Stockholm University, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
